https://scholars.lib.ntu.edu.tw/handle/123456789/569901
標題: | Identification of factors associated with first-cycle drug approval rates and regulatory outcomes for new drug applications | 作者: | LIN-CHAU CHANG Vanheusen M. Fang X. Breder C.D. |
關鍵字: | First-cycle approval; Product attributes | 公開日期: | 2019 | 卷: | 139 | 起(迄)頁: | 166-172 | 來源出版物: | Pharmacological Research | 摘要: | The aims of this study were to identify types of deficiencies resulting in delay of approvals for drugs eventually approved by the US FDA and to search for factors associated with higher first-cycle approval rates. Review documents of New Drug Applications approved between 2008 and 2017 were retrieved from the Drugs@FDA database. Basic characteristics of the applications, regulatory actions, and reasons for non-approvals and/or major amendments after first review cycle were investigated. Of 825 applications studied, 446 (54.1%) applications received first-cycle approvals without a review extension resulting from a major amendment. Non-approvals (240, 29.1%) were based primarily on chemistry/manufacturing/controls and safety reasons. A higher first-cycle approval rate was associated with factors related to unmet medical needs or innovative development. The association between higher first-cycle approval rates and innovative drugs or those addressing unmet needs reveals the FDA's commitment in advancing innovation and protecting public health. ? 2018 |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056964830&doi=10.1016%2fj.phrs.2018.11.004&partnerID=40&md5=ee58bde655e074093aae6e5630efe692 https://scholars.lib.ntu.edu.tw/handle/123456789/569901 |
ISSN: | 10436618 | DOI: | 10.1016/j.phrs.2018.11.004 | SDG/關鍵字: | anticonvulsive agent; antineoplastic agent; antiparkinson agent; antivirus agent; digestive tract agent; vitamin; Article; chemistry; controlled study; correlational study; drug approval; drug control; drug formulary; drug manufacture; drug safety; food and drug administration; priority journal; United States; drug approval; Food and Drug Administration; statistics and numerical data; Drug Approval; United States; United States Food and Drug Administration |
顯示於: | 藥學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。